Skip to content

Clinical trials

Completed Phase 1/2 Cognitive Dysfunction trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Phase: Phase 1/2 Status: Completed Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20132
20161
20182
20194
20201
20212
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital2
AC Immune SA1
Actinogen Medical1
Biomind Labs Inc.1
Chengdu University of Traditional Chinese Medicine1
National Institute of Mental Health (NIMH)1
National University Hospital, Singapore1
Peking University Sixth Hospital1
Perseverance Research Center, LLC1
The University of New South Wales1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction18
Alzheimer Disease7
Dementia5
Anxiety Disorders2
Amyotrophic Lateral Sclerosis1
Autism Spectrum Disorder1
Autistic Disorder1
Brain Diseases1
Central Nervous System Diseases1
Cognition Disorders1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.